Navigation Links
pH Testing - Advanced Analysis

ProductspH Testing - Advanced Analysis
Company Medtronic Gastroenterology
Item pH Testing - Advanced Analysis
Features 
  • Assess the effectiveness of an acid-suppressing pharmacologic agent in terms of the time it takes to raise and maintain gastric pH above a certain level
  • Calculate area under the curve in units of [H+]mmol/L*hrs. and report the median pH and other parameters for predefined time intervals throughout the duration of a pH study
Description Advanced pH Analysis for POLYGRAM NET™ is an add-on option for the pH Testing Application. Like the standard application, Advanced pH Analysis is compatible with data recorded by either the Digitrapper™ Catheter-Based pH Recorder or the Bravo™ Catheter-Free pH Monitoring System.

Designed primarily for use by clinical research organizations it contains more advanced features not found in the standard application.
Info Medtronic Gastroenterology
Customer Service: (763) 514-4000

Related medicine products :

1. D-10 Hemoglobin Testing System with D-10™ Rack Loader
2. Hgb Pro Professional Hemoglobin Testing System
3. ABI Testing Kit
4. StressVue Exercise Stress Testing System
5. Point Of Care Testing (POCT) Information System
6. AAFP-PT Laboratory Proficiency Testing and Quality Assurance
7. Clinical Proficiency Testing Programs
8. VARIANT II TURBO Hemoglobin Testing System
9. Sidekick™ Blood Glucose Testing System
10. Anorectal Function Testing
11. Standard pH Testing Application
Features soft, low friction sheath that extends beyond the tip.
Facilitates intubation of tracheal tubes.
Disposable Aluminum Satin Finish E/T Stylette, Pediatric 11 1/2, 25/box.
Solid Copper Malleable with Adjustable Stop 14.75.
Medicine Products:
(Date:5/16/2008)... study being presented at the American Society of ...20), may change treatment practice in about 25 per...s for proposed changes to the way colorectal cance...ional Cancer Institute (NCI) SEER population-based... III clinical trial data, shows that outcomes of p...
(Date:5/16/2008)... fibroids located just beneath the lining of the u...endometrial cavity after uterine artery embolizati...s, according to a new study. , The study includ...MRI examination before and after UAE. The study fo...% migrated to the endometrial cavity after UAE, sa...
(Date:5/16/2008)...Live Web Cast Scheduled for May 19 at 10:15 a.m. E...all/ - Response Biomedical,Corporation (TSX: RBM, ...hief Executive Officer, is scheduled to present at... Conference on Monday May 19th at 10:15 a.m.,EDT.,...lable on the Company,s,Web site at, http://www.res...
(Date:5/16/2008)...elp docs determine who would benefit most from che... May 16 (HealthDay News) -- A panel of 15 genes ma...on-small cell lung cancer will experience a recurr...erapy, a new study shows. , By extension, the ...with less aggressive forms of the cancer who would...
Breaking Medicine News(10 mins):Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3
...blished online in the Environmental Science & Tech...ty, says that bacteria present in the soil can con... the US to toxic forms that could prove harmful to... of environmental engineers at the University of C...
...ed this week says the government’s program (1999) ...ancially deprived families// and their children be...ers. The program targets individual families with...ved areas. It provides outreach or home visiting, ...
...nd or a relative learns that she has cancer she is...ough this, than about herself//. Questions as to h...keep life normal for them during her treatment oft... help, suggests Raising an Emotionally Healthy Chi...
...a's health minister, Manto Tshabalala-Msimang, cla...ne’s diet would delay the onset of AIDS//. She d... warned about the ill effects of the anti-retrovir...arked outrage among the AIDS activist and the medi...
Other Medicine News:Health News:Bacteria Can Convert Flame Retardant Into Toxic Form 2Health News:Helping a Family Going Through an Illness 2
(Date:5/15/2008)... /- Patients with breast or,colorecta...can expect,further treatment advances with Avastin...ollowing new data that is being presented at the 4...nnual meeting in Chicago at,the end of May. Around...ich,is the premier event for cancer therapy worldw...
(Date:5/15/2008)...SCO Showed Acceptable Tolerability Profile, ...hy, WOODCLIFF LAKE, N.J., May 15 /- ...n mesylate (E7389) demonstrated activity in a,heav...vanced or metastatic,breast cancer, according to r...The study also suggests that eribulin mesylate has...
(Date:5/15/2008)...nstrated in Blacks, Hispanics/Latinos, People ... PARSIPPANY, N.J., May 15 /- Daiichi ...at the American Society of,Hypertension,s Twenty- ...Orleans demonstrated that the powerful combination...l) safely and effectively helped,patients across s...
(Date:5/15/2008)...y 15 /- Ergonex Pharma today,announce...ion (FDA) has,granted orphan drug designation to T...ypertension (PAH). Terguride is currently being ev...ope., "The FDA,s grant of orphan drug designation...ur development program by offering regulatory,cli...
Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2HealthSouth Declares Dividend on 6 5 25 Series A Convertible Perpetual Preferred Stock 2109 1HealthSouth Declares Dividend on 6 5 25 Series A Convertible Perpetual Preferred Stock 2109 2Industry Executives Finding Value in Shift of Scientific Publications 862 1Industry Executives Finding Value in Shift of Scientific Publications 862 2DuPont and Plantic Technologies Announce Starch Based Bio Materials Collaboration 860 1DuPont and Plantic Technologies Announce Starch Based Bio Materials Collaboration 860 2DuPont and Plantic Technologies Announce Starch Based Bio Materials Collaboration 860 3Mylan to Host Investor Day on October 3 2007 858 1
...rofile Reduction of,testosterone concentration was...r Shionogi initiates Phase 2b trial, QUEBEC CITY, ...ntaris Inc. along with its Japanese partner Shiono...s for a Phase 2a trial with,cetrorelix in benign p...pan. Results showed that cetrorelix, the Company,s...
...- Nutra Pharma,Corp. (OTCBB: NPHC), a biotechnolog...tiple Sclerosis has today announced that its,drug ...ification of,acceptance of its paper for publicati...onference issue., The article, entitled "Alpha-Cob...is; a review of the literature leading to its,deve...
Other Medicine Technology:AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 2AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 4Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3